Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid LeukemiaChemically-Induced Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm, psychiatric disorder, substance withdrawal syndrome, substance-related disorderActive, not recruitingPhase 22024-11-26NCT04147533

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Masaryk University33

8 results · Page 1 of 1

Swipe the table sideways for more columns.